Literature DB >> 194058

Friend strain of spleen focus-forming virus: a recombinant between mouse type C ecotropic viral sequences and sequences related to xenotropic virus.

D H Troxler, J K Boyars, W P Parks, E M Scolnick.   

Abstract

The genome of the Friend strain of the spleen focus-forming virus (SFFV) has been analyzed by molecular hybridization. SFFV is composed of genetic sequences homologous to Friend type C helper virus (F-MuLV) and SFFV-specific sequences not present in F-MuLV. These SFFV-specific sequences are present in both the Friend and Rauscher strains of murine erythroleukemia virus. The SFFV-specific sequences are partially homologous to three separate strains of mouse xenotropic virus but not to several cloned mouse ecotropic viruses. Thus, the Friend strain of SFFV appears to be a recombinant between a portion of the F-MuLV genome and RNA sequences that are highly related to murine xenotropic viruses. The implications of the acquisition of the xenotropic virus-related sequences are discussed in relation to the leukemogenicity of SFFV, and a model for the pathogenicity of other murine leukemia-inducing viruses is proposed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 194058      PMCID： PMC515727     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  36 in total

1.  AN UNIDENTIFIED VIRUS WHICH CAUSES THE RAPID PRODUCTION OF TUMOURS IN MICE.

Authors:  J J HARVEY
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

Review 2.  Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations.

Authors:  R A Steeves
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

3.  Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.

Authors:  J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

4.  A virus-induced disease of mice characterized by erythrocytopoiesis and lymphoid leukemia.

Authors:  F J RAUSCHER
Journal:  J Natl Cancer Inst       Date:  1962-09       Impact factor: 13.506

5.  An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C, and the feline--primate viruses RD-114/CCC/M-7.

Authors:  P T Peebles
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

6.  A biochemical and genetic analysis of mammalian RNA-containing sarcoma viruses.

Authors:  E M Scolnic; R J Goldberg; W P Parks
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

7.  Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end.

Authors:  L H Wang; P Duesberg; K Beemon; P K Vogt
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

8.  Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus.

Authors:  E M Scolnick; R S Howk; A Anisowicz; P T Peebles; C D Scher; W P Parks
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

9.  Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice.

Authors:  M LIEBERMAN; H S KAPLAN
Journal:  Science       Date:  1959-08-14       Impact factor: 47.728

10.  Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.

Authors:  C FRIEND
Journal:  J Exp Med       Date:  1957-04-01       Impact factor: 14.307
View more
  59 in total

1.  Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv.

Authors:  K S Jones; S Ruscetti; F Lilly
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Structure of 50 to 70S RNA from Moloney sarcoma viruses.

Authors:  J Maisel; W Bender; S Hu; P H Duesberg; N Davidson
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

3.  Identification of a 30S RNA with properties of a defective type C virus in murine cells.

Authors:  R S Howk; D H Troxler; D Lowy; P H Duesberg; E M Scolnick
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

4.  High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures.

Authors:  W Bender; Y H Chien; S Chattopadhyay; P K Vogt; M B Gardner; N Davidson
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

5.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

Authors:  J H Elder; J W Gautsch; F C Jensen; R A Lerner; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.

Authors:  D H Troxler; D Lowy; R Howk; H Young; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus.

Authors:  R J Eckner; K L Hettrick
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

8.  Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation.

Authors:  D L Linemeyer; J G Menke; S K Ruscetti; L H Evans; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Molecular cloning of biologically active Rauscher spleen focus-forming virus and the sequences of its env gene and long terminal repeat.

Authors:  R K Bestwick; B A Boswell; D Kabat
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  Heteroduplex analysis of molecular clones of the pathogenic Friend virus complex: Friend murine leukemia virus, Friend mink cell focus-forming virus, and the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus.

Authors:  M A Gonda; J Kaminchick; A Oliff; J Menke; K Nagashima; E M Scolnick
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.